A detailed history of Hood River Capital Management LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Hood River Capital Management LLC holds 1,433,934 shares of VRNA stock, worth $76.9 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
1,433,934
Previous 1,062,456 34.96%
Holding current value
$76.9 Million
Previous $15.4 Million 168.53%
% of portfolio
0.76%
Previous 0.38%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.46 - $30.16 $5.74 Million - $11.2 Million
371,478 Added 34.96%
1,433,934 $41.3 Million
Q2 2024

Aug 14, 2024

BUY
$11.48 - $17.02 $857,556 - $1.27 Million
74,700 Added 7.56%
1,062,456 $15.4 Million
Q1 2024

May 15, 2024

BUY
$15.3 - $20.24 $629,656 - $832,956
41,154 Added 4.35%
987,756 $15.9 Million
Q4 2023

Feb 14, 2024

BUY
$11.94 - $20.47 $11.3 Million - $19.4 Million
946,602 New
946,602 $18.8 Million

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $3.27B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Hood River Capital Management LLC Portfolio

Follow Hood River Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hood River Capital Management LLC with notifications on news.